Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An update from TruBridge ( (TBRG) ) is now available.
On February 11, 2025, TruBridge, Inc. announced cooperation agreements with Pinetree Capital Ltd. and Ocho Investments LLC, its two largest investors. Through these agreements, TruBridge expanded its board of directors by appointing Jerry Canada and Dris Upitis as independent directors, reflecting its commitment to strong corporate governance and value creation for stockholders. The agreements include initiatives like declassifying the board and terminating the stockholder rights plan, indicating a strategic move to enhance operational effectiveness and growth. The company’s CEO, Chris Fowler, emphasized that these changes align with TruBridge’s long-term strategy to capitalize on growth opportunities and strengthen its industry positioning.
More about TruBridge
TruBridge, Inc. is a healthcare solutions company that partners with over 1,500 healthcare organizations. It provides technology-first solutions that address the unique needs and challenges of diverse communities, focusing on equitable access to quality care and fostering positive outcomes. TruBridge’s offerings include a suite of revenue cycle management (RCM) services and electronic health record (EHR) products, aimed at enhancing productivity and supporting the financial health of healthcare organizations.
YTD Price Performance: 36.48%
Average Trading Volume: 89,585
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $380.9M
For detailed information about TBRG stock, go to TipRanks’ Stock Analysis page.
